Global Patent Index - EP 1161147 A4

EP 1161147 A4 20020724 - PEPTIDE MIMICS USEFUL FOR TREATING DISEASE

Title (en)

PEPTIDE MIMICS USEFUL FOR TREATING DISEASE

Title (de)

PEPTID-MIMETIKA ZUR BEHANDLUNG VON KRANKHEITEN

Title (fr)

MIMETIQUES PEPTIDIQUES UTILES POUR TRAITER DES MALADIES

Publication

EP 1161147 A4 20020724 (EN)

Application

EP 98964947 A 19981224

Priority

US 9827633 W 19981224

Abstract (en)

[origin: WO0038515A1] The present invention provides a method of treating disease, such as melanoma, in a mammal comprising treating the mammal with an effective amount of a peptide mimic that elicits an immune response against a target molecule associated with a disease.

IPC 1-7

A01N 37/18; A61K 38/00; A61K 39/39; C07K 7/00; C12N 15/00

IPC 8 full level

C12N 15/09 (2006.01); A61K 35/76 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61K 45/00 (2006.01); A61K 45/08 (2006.01); A61K 47/48 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01)

CPC (source: EP US)

A61K 39/001171 (2018.08 - EP US); A61P 35/00 (2018.01 - EP); A61P 37/00 (2018.01 - EP); A61K 2039/5154 (2013.01 - EP); A61K 2039/6081 (2013.01 - EP)

Citation (search report)

  • [A] EP 0668350 A1 19950823 - AKZO NOBEL NV [NL]
  • [A] WO 9734613 A1 19970925 - UNIV VIRGINIA [US]
  • [A] WO 8911296 A1 19891130 - FERRONE SOLDANO [US], et al
  • [X] PARKHURST ET AL: "Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues", JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, vol. 157, 1996, pages 2539 - 2548, XP002096010, ISSN: 0022-1767
  • [X] DYALL R ET AL: "HETEROCLITIC IMMUNIZATION INDUCES TUMOR IMMUNITY", JOURNAL OF EXPERIMENTAL MEDICINE, TOKYO, JP, vol. 188, no. 9, 2 November 1998 (1998-11-02), pages 1553 - 1561, XP002947142, ISSN: 0022-1007
  • [X] ROSENBERG S A ET AL: "Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma", NATURE MEDICINE, NATURE PUBLISHING, CO, US, vol. 4, no. 3, 1 March 1998 (1998-03-01), pages 321 - 327, XP002091661, ISSN: 1078-8956
  • [X] BAKKER A B H ET AL: "ANALOGUES OF CTL EPITOPES WITH IMPROVED MHC CLASS-I BINDING CAPACITY ELICIT ANTI-MELANOMA CTL RECOGNIZING THE WILD-TYPE EPITOPE", INTERNATIONAL JOURNAL OF CANCER, NEW YORK, NY, US, vol. 70, no. 3, 1997, pages 302 - 309, XP000917224, ISSN: 0020-7136
  • [A] CORTESE R ET AL: "Identification of biologically active peptides using libraries displayed on phage", CURRENT OPINION IN BIOTECHNOLOGY, LONDON, GB, vol. 6, no. 1, 1995, pages 73 - 80, XP002107140, ISSN: 0958-1669
  • [A] HOESS R ET AL: "IDENTIFICATION OF A PEPTIDE WHICH BINDS TO THE CARBOHYDRATE-SPECIFIC MONOCLONAL ANTIBODY B3", GENE, ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, NL, vol. 1, no. 128, 15 June 1993 (1993-06-15), pages 43 - 49, XP001071246, ISSN: 0378-1119
  • [A] MITTELMAN A ET AL: "HUMAN HIGH MOLECULAR WEIGHT MELANOMA-ASSOCIATED ANTIGEN (HMW-MAA) MIMICRY BY MOUSE ANTI-IDIOTYPIC MONOCLONAL ANTIBODY MK2-23: INDUCTION OF HUMORAL ANTI-HMW-MAA IMMUNITY AND PROLONGATION OF SURVIVAL IN PATIENTS WITH STAGE IV MELANOMA", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 89, 1992, pages 466 - 470, XP000887127, ISSN: 0027-8424
  • [A] PARMIANI G: "Future perspectives in specific immunotherapy of melanoma", EUROPEAN JOURNAL OF CANCER, PERGAMON PRESS, OXFORD, GB, vol. 34, April 1998 (1998-04-01), pages 42 - 47, XP004284900, ISSN: 0959-8049
  • See also references of WO 0038515A1

Designated contracting state (EPC)

AT BE CH DE DK ES FR GB IE IT LI NL SE

DOCDB simple family (publication)

WO 0038515 A1 20000706; AU 2016199 A 20000731; CA 2334958 A1 20000706; EP 1161147 A1 20011212; EP 1161147 A4 20020724; JP 2002533357 A 20021008

DOCDB simple family (application)

US 9827633 W 19981224; AU 2016199 A 19981224; CA 2334958 A 19981224; EP 98964947 A 19981224; JP 2000590480 A 19981224